MedMira (MedMira) Dividend Payout Ratio : 0.00 (As of Jan. 2024)

View and export this data going back to . Start your Free Trial

What is MedMira Dividend Payout Ratio?

MedMira's dividend payout ratio for the months ended in Jan. 2024 was 0.00.

The historical rank and industry rank for MedMira's Dividend Payout Ratio or its related term are showing as below:

MMIRF's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-22), the Dividend Yield % of MedMira is 0.00%.

MedMira's Dividends per Share for the months ended in Jan. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

MedMira Dividend Payout Ratio Historical Data

The historical data trend for MedMira's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Dividend Payout Ratio Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Dividend Payout Ratio

Get a 7-Day Free Trial

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of MedMira's Dividend Payout Ratio

For the Biotechnology subindustry, MedMira's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMira's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where MedMira's Dividend Payout Ratio falls into.

MedMira Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

MedMira's Dividend Payout Ratio for the fiscal year that ended in Jul. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jul. 2023 )	/	EPS without NRI (A: Jul. 2023 )
	=	0	/	-0.003
	=	N/A

MedMira's Dividend Payout Ratio for the quarter that ended in Jan. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jan. 2024 )	/	EPS without NRI (Q: Jan. 2024 )
	=	0	/	-0.001
	=	N/A

MedMira (OTCPK:MMIRF) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

MedMira Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of MedMira's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (MedMira) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

47M:Germany MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.